Notably, CCL7, TAPBP, and ICAM1 were leading edge genes for all three pathways, and both CCL7 and ICAM1 were also trending up in the 14-day primary tumor proteomic analysis (Fig 6B). This evidence concerns the gene TAPBP and neoplasm.